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Abstract
Background: Cigarette smoking is a strong risk factor for vascular disease and known to cause
dysfunction of the endothelium. However, the molecular mechanisms involved are still not fully
understood.
Methods: In order to reveal the direct effects of lipid-soluble smoke particles on the endothelium,
ring segments isolated from rat mesenteric arteries and human middle cerebral arteries (MCA)
obtained at autopsy were incubated for 6 to 48 hrs in the presence of dimethylsulphoxide (DMSO)-
soluble particles from cigarette smoke (DSP), i.e. lipid-soluble smoke particles. The endothelial
microstructure was examined by transmission electron microscopy. The endothelial function was
evaluated by acetylcholine (ACh)-induced endothelium-dependent vasodilatation, using a sensitive
myograph.
Results: After DSP treatment, the arterial endothelium was swollen and loosing its attachment. In
functional tests, the total ACh-induced dilatation, the nitric oxide (NO)-mediated and the
endothelium-derived hyperpolarization factor (EDHF)-mediated dilatations were significantly
decreased by DSP in a time- and concentration-dependent manner (p < 0.05). Nicotine, an
important compound in cigarette smoke had, in an equivalent concentration as in DSP, no such
effects (p > 0.05). Similar results were obtained in the human MCA.
Conclusion: Thus, we demonstrate that the lipid-soluble smoke particles, but not nicotine, caused
damage to arterial endothelium and reduced the endothelium-dependent dilatation in man and rat.
Background
Cigarette smoking has since long been recognized as a
strong risk factor for the development of vascular disease
such as hypertension, stroke and coronary heart disease
[1,2]. Tobacco smoking is associated with increased
intima-media thickness (IMT) of carotid and femoral
arteries, elevated levels of circulating C-reactive protein
(CRP), and correlates with atherosclerotic vascular dis-
ease. Although the inhaled smoke from the combustion
of tobacco is known to cause development atherosclerotic
vascular disease [3], however the mechanisms behind this
are still elusive. Damage to endothelium-dependent
vasodilatation induced by cardiovascular risk factors like
cigarette smoke particles is believed to be involved in the
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development of vascular disease. Previously, we have
demonstrated that dimethylsulfoxide (DMSO)-soluble
particles from cigarette smoke (DSP), i.e. lipid-soluble
smoke particles are toxic to cultured arterial endothelial
(EC) and smooth muscle cells (SMC) [4,5]. A recent study
showed that nicotine attenuates acetylcholine (ACh)-
induced endothelium-dependent relaxation [6]. How-
ever, the role of nicotine in the development of cardiovas-
cular disease is still being debated, since nicotine
replacement by chewing tobacco or using moist snuff
does not appear to have as many associated cardiovascu-
lar risks as smoking does [7].
Arterial endothelium possesses a number of important
functions involved in regulation of vascular tone, prolifer-
ation and remodeling. Damage to the endothelium plays
an important role in the development of atherosclerotic
cardiovascular diseases [8]. We have previously demon-
strated that organ culture of rat mesenteric arteries induces
loss of nitric oxide (NO)- and prostaglandin-mediated
vasodilatation, while this is compensated for by a stronger
endothelium dependent hyperpolarization factor (EDHF)
response, suggesting a shift of endothelium-mediated
vasodilator mechanisms [9]. Cardiovascular risk factors
like smoking may cause vascular disease via damage to
endothelium-dependent vasodilatation.
The present study was designed, by using organ culture as
a model, to investigate if lipid-soluble smoke particles
cause damage to the endothelium and reduce the
endothelium-dependent vasodilatation in man and in rat.
Methods
Reagents
Acetylcholine (ACh), 5-hydroxytryptamine (5-HT), NG-
nitro-L-arginine methyl ester (L-NAME), apamin, charyb-
dotoxin, indomethacin, nicotine, DMSO (Dimethyl Sul-
phoxide) and DMEM (Dulbecco's modified Eagle's
medium) were purchased from Sigma, St. Louis, USA. All
substances were dissolved in 0.9 % saline, except
indomethacin and nicotine that were dissolved in DMSO.
Extraction of DSP
Three cigarettes (0.8 mg nicotine per cigarette) were
"smoked" by a water aspirator and the smoke was directed
through a cotton wool filter. The retained smoke particles
in the filter were dissolved in 1 ml DMSO. The DMSO-sol-
uble smoke particle (DSP) preparations were analyzed by
gas chromatograph-flame ionisation detection (GC-FID,
Agilent 6890N, USA) with a 0.23 mm × 15 mm × 0.25 m
DB-5MS capillary column (Agilent, USA). The GC-FID
temperatures were programmed from 50°C, increased
with 5°C/min to 280°C and remained for 3 min. The con-
centration of nicotine in DSP was calculated according to
standard nicotine peak value and area. After DSP prepara-
tions have been analyzed by the gas chromatograph, they
were diluted by DMSO to standard nicotine content (0.11
mg/L) and used for organ culture experiments.
Tissue preparation
Sprague-Dawley rats (250~300 g, male or female) were
euthanized with CO2, the head cut off and exsanguinated.
The superior mesenteric artery was removed gently,
immersed in cold oxygenated buffer solution (in mM:
NaCl 119, NaHCO3 15, KCl 4.6, MgCl2 1.2, NaH2PO4 1.2,
CaCl2 1.5, glucose 5.5, pH 7.4) and dissected free of
adhering tissue under a light microscope. Human middle
cerebral arteries (MCA) were obtained from 3 subjects
from the Department of Forensic Medicine of Xian Jiao-
tong University (China). The arteries were collected from
three men and used for organ culture between 4 to 6 hrs
after death due to a traffic accident. The experimental pro-
tocol for using rat and human arteries was approved by
local Ethic's Committee of Shaanxi province (China).
Organ culture
The vessels were cut into 1 mm long cylindrical segments
and placed in a 96-well plate, one segment in each well,
containing 300 µl Dulbecco's modified Eagle's medium
(DMEM) containing L-glutamine (584 mg/l) and supple-
mented with penicillin (100 U/ml) and streptomycin
(100 µg/ml). The vessel segments were incubated for 6~48
h in the presence of DSP, the same volumes of DMSO as
control or nicotine (0.11 mg/L) at 37°C in humidified 5
% CO2.
In vitro pharmacology
The vessel segments were mounted on two L-shaped
metal prongs. One prong was connected to a force dis-
placement transducer (FT-03C) attached to a PowerLab
(ADInstruments) unit for continuous recording of iso-
metric force by means of the Chart software (ADInstru-
ments). The other prong was connected to a displacement
device, allowing fine adjustment of the distance between
the two parallel prongs.
The mounted segments were immersed in tissue baths
containing buffer solution, which was aerated continu-
ously with a gas mixture of 95 % O2 and 5 % CO2 and
maintained at 37°C. The artery segments were equili-
brated for 1.5 h with a resting tension of 2.5 mN before
the experiments were started. The contractile capacity of
each vessel segment was examined by exposure to a K+-
rich (60 mM) buffer solution in which NaCl was
exchanged for an equimolar concentration of KCl. When
two reproducible contractions had been achieved the ves-
sels were used for further experiments.
After equilibration, the vessels were preconstricted with 5-
HT (20 µM) or U46619 (1 µM). Once the sustained ten-BMC Cardiovascular Disorders 2006, 6:3 http://www.biomedcentral.com/1471-2261/6/3
Page 3 of 9
(page number not for citation purposes)
Endothelial microstructure Figure 1
Endothelial microstructure. Rat mesenteric artery incubated with vehicle (DMSO 0.4 ml/L, A, B and C) or DSP (0.4 ml/L, E, F 
and G) for 24 hrs. Human MCA incubated with vehicle (DMSO 0.8 ml/L, D) or DSP (0.8 ml/l, H) for 12 hrs. Magnification: × 
3000 for A and E; × 5000 for B, F, D and H; × 10000 for C and G. EC = endothelial cells; SMC = smooth muscle cells; EM = 
elastic membrane.
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ACh-induced vasodilatation Figure 2
ACh-induced vasodilatation. The vasodilatation induced by ACh (10-6 M) in the 5-HT (2 × 10-5 M) preconstricted rat 
mesenteric artery segments cultured with DSP for 6 (A), 12 (B), 24 (C), 48 hrs (D) and the time course (G). ACh-induced 
vasodilatation in human MCA preconstricted by 1 µM of U46619 after treated with DSP 0.8 ml/L for 6 (E) and 12 hrs (F). Same 
volume of DMSO served as control. Data are derived from 8 segments and shown as mean ± S.E.M. *p < 0.05 and **p < 0.01 
vs. control.
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Characterizations of ACh-induced vasodilatation Figure 3
Characterizations of ACh-induced vasodilatation. (A) Changes in ACh-induced EDHF mediated vasodilatations on the 5-HT 
preconstricted rat mesenteric arteries after treated with DSP for 12 hours. The tests were performed in the presence of 
indomethacin (10-5 M) and L-NAME (10-4 M). (B) Changes in ACh-induced NO mediated vasodilatations on the 5-HT precon-
stricted rat mesenteric arteries after treated with DSP for 12 hours. The tests were done in the presence of indomethacin, 
charybdotoxin (5 × 10-8 M) and apamin (10-6 M). (C) Changes in ACh-induced PG mediated vasodilatations on the 5-HT pre-
constricted rat mesenteric arteries after treated with DSP for 12 hours. The tests were done in the presence of charyb-
dotoxin, apamin and L-NAME. Each data points derived from 8 experiments and shown as mean ± S.E.M. *p < 0.05 and **p < 
0.01 vs. control.
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Effects of nicotine in comparison with DSP on ACh-induced vasodilatation Figure 4
Effects of nicotine in comparison with DSP on ACh-induced vasodilatation. Concentration 0.11 mg/L of nicotine that is nicotine 
concentration in DSP was used. Since nicotine and smoke particles were dissolved in DMSO, the same volume of DMSO was 
added in the culture medium and served as controls. The arteries treated with nicotine or DSP for 6 (A) and 12 hrs (B). Data 
are shown as mean ± S.E.M. n = 8. *p < 0.05 and **p < 0.01 vs. control.
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sion was obtained, ACh (10-6 M) or cumulative ACh from
10-10 to 10-4 was added to the baths and the isometric ten-
sion was recorded. Vasodilatation was expressed as per-
centage of preconstriction with 5-HT or U46619. Nitric
oxide (NO)-mediated dilatation induced by ACh was
studied in the presence of 10 µM indomethacin, 50 nM
charybdotoxin and 1 µM apamin. Endothelium-derived
hyperpolarising factor (EDHF) was studied in the pres-
ence of 0.1 mM L-NAME and indomethacin. Prostagland-
ins (PG) were studied in the presence of L-NAME,
charybdotoxin and apamin. The antagonists were added
20 minute before administration of 5-HT or U46619 pre-
constriction.
Vascular microstructure
For studying vascular microstructure, a transmission elec-
tron microscopy (TEM, H-600, Hiatachi, Japan) was used.
The fresh vessels were sectioned at 1 mm × 3 mm × 3 mm
and fixed with 2.5 % Glutaraldehyde + 4 % Paraformalde-
hyde in phosphate buffer for 2 hours at 4°C, and washed
with 0.1 M phosphate buffer for 30 min. The second fixa-
tion used was 1 % osmium tetroxide in phosphate buffer
for 2 hours at 4°C, then washed with 2 – 3 changes of 0.1
M phosphate buffer, dehydrated with graded series of
alcohol, immersed in mixture of propylene oxide + epon
812 for 1 hour or over night at 37°C. Then, they were
exposed to a mixture of epon 812 for 1 hour at 60°C,
embedded and polymerized for 48 hours at 60°C. Using
Ultrathin Sectioning: LKB-V (LKB, Sweden) and sectioned
at 50 – 70 nm, stained with uranyl acetate and lead
hydroxide for 10 min, and subsequently examined in the
transmission electron microscope.
Calculation and statistics
The vasodilatation effects of ACh were expressed as per-
centage of preconstriction by agonists. Data were
expressed as mean ± SEM. Student's t-test or two-way
ANOVA with Bonferroni post-test was used to analyze dif-
ference between groups. The P-value of less than 0.05 was
considered to be significant.
Results
Microstructure of artery endothelium
In control (DMSO) group, arterial endothelial cells were
flat, clinging to the elastic membrane. There were junction
structures between cells with microvillus-like lugs on the
surface of the cell membranes. After exposure to DSP (0.4
ml/L) for 24 hrs, the endothelium was swollen and loose
in rat mesenteric arteries (Fig. 1A-C and 1E-G), demon-
strating that DSP caused damage to the arterial endothe-
lium. In human middle cerebral arteries (MCA), after
organ culture in the presence of DSP 0.8 ml/L for 12 h,
similar damage to the endothelium was seen (Fig. 1D and
1H).
Endothelium dependent dilations
After 6 to 48 hrs of incubation with different concentra-
tions of DSP (0.05–1.6 ml/L), the ACh-induced dilatation
in rat mesenteric arterial segments was significantly atten-
uated over time (Fig. 2A-D and 2G), while in the control
(DMSO) group, it was not significantly changed.
Human MCA segments were organ cultured for 6 or 12 hrs
in the presence of DSP (0.8 ml/L). Similar results were
obtained as in rat mesenteric arteries with a reduction of
the ACh-induced vasodilatation (Fig. 2E-F).
EDHF-mediated dilatations
To study EDHF-mediated dilatation, the vessel segments
were incubated for 12 hrs with DSP (0.8 ml/L), precon-
tracted with 5-HT (2 × 10-5 M) and relaxed by cumulative
application of ACh (10-10~10-4 M) in the presence of L-
NAME (10-4 M) and indomethacin (10-5 M). The maximal
dilatation was significantly lower in DSP-treated than in
the control (DMSO) group (P < 0.01) (Fig. 3A).
NO-mediated dilatations
To study NO-mediated dilatation, indomethacin (10-5
M), charybdotoxin (5 × 10-8 M) and apamin (10-6 M) were
used to block prostaglandin and EDHF mediated effects.
The experiments were otherwise performed as above. The
maximal NO-mediated dilatation was significantly
reduced in DSP-treated segments as compared to the con-
trol group (P < 0.01) (Fig. 3B).
PG-mediated dilatations
The vessel segments were studied as above but in the pres-
ence of L-NAME (10-4 M), charybdotoxin (5 × 10-8 M) and
apamin (10-6 M) to block NO- and EDHF-mediated relax-
ation. The maximal PG-dilatation was slight or near nil.
There were no observable differences between the control
and the DSP treated groups (Fig. 3C).
Comparison of DSP with nicotine
DSP contains 0.11 mg/L of nicotine and thus this concen-
tration was used to examine if nicotine was the key sub-
stance in the DSP-induced reduction of vasodilatation.
Compared to nicotine, DSP had a significantly stronger
effect in reducing the ACh-induced dilatation. However,
in comparison with DMSO (control) nicotine did not
produce any significant reduction of vasodilatation (Fig.
4).
Discussion
The present study has revealed that lipid-soluble cigarette
smoke particles "DSP", but not nicotine in equivalent
concentration, caused damage to the artery endothelium
and reduced the endothelium-dependent relaxation in rat
mesenteric artery and in human MCA. This agrees well
with previous findings since DSP has been found to causeBMC Cardiovascular Disorders 2006, 6:3 http://www.biomedcentral.com/1471-2261/6/3
Page 8 of 9
(page number not for citation purposes)
damage to cultured arterial EC and SMC cells [4]. The
endothelium has many important functions such as regu-
lating arterial tone, antithrombosis, release of growth fac-
tors and growth inhibitors as well as expressing vascular
adhesion molecules [4,8]. Studies in active and passive
smoking subjects have shown that they have impaired
endothelial function [10]. According to the "response to
injury" hypothesis of atherosclerosis, dysfunction of
endothelium is an early event in the development of
atherosclerotic vascular disease. Thus, the present study
unveils a link between cigarette smoking and vascular dis-
ease, since lipid-soluble smoke particles (DSP) caused
endothelial damage and dysfunction. However, nicotine,
an important compound in cigarette smoking, in an
equivalent concentration as in DSP, did not show such
effects.
The ACh-induced endothelium-dependent relaxation
consists of NO-, PG- and EDHF-mediated vasodilatation
[9]. NO is generated by nitric oxide synthase (NOS) and
inhibited by the NOS inhibitor L-NAME [11]. This results
in relaxation of vascular smooth muscle by activating gua-
nylate cyclase. Cyclo-oxygenase (COX) converts arachi-
donic acid to prostaglandins that relax vascular smooth
muscle by activating adenylate cyclase. Prostaglandin for-
mation can be inhibited by a general COX inhibitor
indomethacin. EDHF is distinct from NO and prostaglan-
dins, which hyperpolarizes and relaxes smooth muscle
cells. Both its vasodilator and hyperpolarizing effects can
be inhibited by a combination of potassium channel
inhibitor charybdotoxin and apamin [12]. L-NAME,
indomethacin, charybdotoxin and apamin were used in
the present study to define the pathway of endothelium-
dependent relaxation [9] altered by DSP. The results show
that reduction of NO- and EDHF-mediated vasodilatation
by DSP occurred together with damage to the endothelial
microstructure, while PG-mediated vasodilatation was
not altered. NO and EDHF are important vasodilator sub-
stances derived from the endothelium. Damage to NO-
and EDHF-mediated endothelium-dependent relaxations
by lipid-soluble smoke particles is favorable to vasocon-
strictor domination in vascular disease such as hyperten-
sion. Epidemiological studies have shown that smoking
and hyperlipidemia are synergistic risk factors [1]. We
have previously demonstrated that DMSO-soluble parti-
cles from cigarette smoke are directly toxic to cultured
arterial endothelial and smooth muscle cells [4,5]. Lipid-
soluble smoke particles in blood are transported by lipo-
proteins to the arterial wall [13] and thus may directly
impair the function of endothelial cells or cause damage
to the arterial wall via modification of lipoprotein proper-
ties [5].
Nicotine replacement by chewing tobacco or using moist
snuff appears as an opportunity to reduce tobacco smok-
ing-related cardiovascular harm since most smokers
inhale smoke in order to obtain a rapid rise in the nicotine
level in blood. Smoke-free tobacco users who chew
tobacco or take moist snuff have lower risk for cardiovas-
cular disease than tobacco smokers [14]. In the WHO car-
diovascular risk factor project in Sweden two case-control
studies have shown no increase in risk for myocardial inf-
arction by using moist snuff [15]. Theses studies suggest
that tobacco is more harmful when it is smoked. Chewing
tobacco or application of moist snuff gets water soluble
particles into the blood while smoking in addition leads
the lipid-soluble particles through the lung to enter the
blood. Different properties of particles from tobacco may
explain the different effects on cardiovascular disease
between chewing tobacco and inhaling smoked tobacco.
In the present study, we have shown that lipid-soluble
smoke particles caused damage to the arterial endothe-
lium, while nicotine in an equivalent concentration as in
DSP, did not alter endothelium-dependent vasodilata-
tion. This suggests that it is not nicotine per se in DSP that
caused the reduction of vasodilatation. However, nicotine
has been reported to cause damage to endothelium-
dependent relaxation [6]. The different experimental pro-
tocols, species and arteries used may explain the differ-
ence.
Conclusion
We have here demonstrated that lipid-soluble smoke par-
ticles, but not nicotine, cause damage to the arterial
endothelium and reduced the endothelium-dependent
dilatation in man and rat.
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